The role of hyaluronic acid in SEB-induced acute lung inflammation

Clinical Immunology

Volumn 146, Issue 1, 2013, Pages 56-69

  Uchakina, Olga N ^a   Castillejo, Clara M ^a   Bridges, Christy C ^a   McKallip, Robert J ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung inflammation; Extracellular matrix; Hyaluronic acid; Staphylococcal enterotoxin B (SEB)

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID SYNTHASE; HYALURONIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; PEPTIDE DERIVATIVE; PROTEIN PEP 1; STAPHYLOCOCCUS ENTEROTOXIN B; SYNTHETASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SPLEEN CELL;

ACUTE DISEASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; ENDOTHELIAL CELLS; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INFLAMMATION MEDIATORS; LUNG; MICE; MICE, INBRED C57BL; PEPTIDES; PNEUMONIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN;

EID: 84870896939     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.11.002     Document Type: Article

References (42)

1. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Fosheim G.E., McDougal L.K., Carey R.B., Fridkin S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
2. Strandberg K.L., Rotschafer J.H., Vetter S.M., Buonpane R.A., Kranz D.M., Schlievert P.M. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J. Infect. Dis. 2010, 202:1690-1697.
3. Schramm R., Thorlacius H. Staphylococcal enterotoxin B-induced acute inflammation is inhibited by dexamethasone: important role of CXC chemokines KC and macrophage inflammatory protein 2. Infect. Immun. 2003, 71:2542-2547.
4. McKallip R.J., Fisher M., Do Y., Szakal A.K., Gunthert U., Nagarkatti P.S., Nagarkatti M. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J. Biol. Chem. 2003, 278:43818-43830.
5. Madsen J.M. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin. Lab. Med. 2001, 21:593-605.
6. Gaggar A., Jackson P.L., Noerager B.D., O'Reilly P.J., McQuaid D.B., Rowe S.M., Clancy J.P., Blalock J.E. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J. Immunol. 2008, 180:5662-5669.
7. O'Reilly P.J., Gaggar A., Blalock J.E. Interfering with extracellular matrix degradation to blunt inflammation. Curr. Opin. Pharmacol. 2008, 8:242-248.
8. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 2006, 85:699-715.
9. Li Z., Potts E.N., Piantadosi C.A., Foster W.M., Hollingsworth J.W. Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide. J. Immunol. 2010, 185:6891-6898.
10. Nakamura K., Yokohama S., Yoneda M., Okamoto S., Tamaki Y., Ito T., Okada M., Aso K., Makino I. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J. Gastroenterol. 2004, 39:346-354.
11. Sun J., Law G.P., Bridges C.C., McKallip R.J. CD44 as a novel target for treatment of staphylococcal enterotoxin B-induced acute inflammatory lung injury. Clin. Immunol. 2012, 144:41-52.
12. Yasuda M., Nakano K., Yasumoto K., Tanaka Y. CD44: functional relevance to inflammation and malignancy. Histol. Histopathol. 2002, 17:945-950.
13. Nishiyama T., Mishima K., Ide F., Yamada K., Obara K., Sato A., Hitosugi N., Inoue H., Tsubota K., Saito I. Functional analysis of an established mouse vascular endothelial cell line. J. Vasc. Res. 2007, 44:138-148.
14. Udaka K. Proc. Soc. Exp. Biol. Med. 1970, 133:1384.
15. Rafi A.Q., Zeytun A., Bradley M.J., Sponenberg D.P., Grayson R.L., Nagarkatti M., Nagarkatti P.S. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J. Immunol. 1998, 161:3077-3086.
16. Rafi-Janajreh A.Q., Chen D., Schmits R., Mak T.W., Grayson R.L., Sponenberg D.P., Nagarkatti M., Nagarkatti P.S. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol. 1999, 163:1619-1627.
17. McKallip R.J., Fisher M., Do Y., Szakal A.K., Gunthert U., Nagarkatti P.S., Nagarkatti M. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by IL-2 activated cytolytic lymphocytes. J. Biol. Chem. 2003, 278:43818-43830.
18. Kolli D., Bataki E.L., Spetch L., Guerrero-Plata A., Jewell A.M., Piedra P.A., Milligan G.N., Garofalo R.P., Casola A. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 2008, 82:8560-8569.
19. Tate M.D., Ioannidis L.J., Croker B., Brown L.E., Brooks A.G., Reading P.C. The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One 2011, 6:e17618.
20. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
21. Vigetti D., Genasetti A., Karousou E., Viola M., Moretto P., Clerici M., Deleonibus S., De Luca G., Hascall V.C., Passi A. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-kappaB (NF-kappaB) pathway. J. Biol. Chem. 2010, 285:24639-24645.
22. Kultti A., Pasonen-Seppanen S., Jauhiainen M., Rilla K.J., Karna R., Pyoria E., Tammi R.H., Tammi M.I. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp. Cell Res. 2009, 315:1914-1923.
23. Liang J., Jiang D., Jung Y., Xie T., Ingram J., Church T., Degan S., Leonard M., Kraft M., Noble P.W. Role of hyaluronan and hyaluronan-binding proteins in human asthma. J. Allergy Clin. Immunol. 2011, 128(403-411):e403.
24. Soderberg M., Bjermer L., Hallgren R., Lundgren R. Increased hyaluronan (hyaluronic acid) levels in bronchoalveolar lavage fluid after histamine inhalation. Int. Arch. Allergy Appl. Immunol. 1989, 88:373-376.
25. Bousquet J., Chanez P., Lacoste J.Y., Enander I., Venge P., Peterson C., Ahlstedt S., Michel F.B., Godard P. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J. Allergy Clin. Immunol. 1991, 88:649-660.
26. Cheng G., Swaidani S., Sharma M., Lauer M.E., Hascall V.C., Aronica M.A. Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. Matrix Biol. 2011, 30:126-134.
27. Dentener M.A., Vernooy J.H., Hendriks S., Wouters E.F. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 2005, 60:114-119.
28. Bracke K.R., Dentener M.A., Papakonstantinou E., Vernooy J.H., Demoor T., Pauwels N.S., Cleutjens J., van Suylen R.J., Joos G.F., Brusselle G.G., Wouters E.F. Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice. Am. J. Respir. Cell Mol. Biol. 2010, 42:753-761.
29. Mayer D., Branscheid D. Exposure of human lung fibroblasts to ozone: cell mortality and hyaluronan metabolism. J. Toxicol. Environ. Health 1992, 35:235-246.
30. Garantziotis S., Li Z., Potts E.N., Kimata K., Zhuo L., Morgan D.L., Savani R.C., Noble P.W., Foster W.M., Schwartz D.A., Hollingsworth J.W. Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J. Biol. Chem. 2009, 284:11309-11317.
31. Li Z., Potts-Kant E.N., Garantziotis S., Foster W.M., Hollingsworth J.W. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. PLoS One 2011, 6:e27137.
32. Boodoo S., Spannhake E.W., Powell J.D., Horton M.R. Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L479-L486.
33. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
34. Hershon L.E. Elaboration of hyaluronidase and chondroitin sulfatase by microorganisms inhabiting the gingival sulcus: evaluation of a screening method for periodontal disease. J. Periodontol. 1971, 42:34-36.
35. Yoshida M., Sai S., Marumo K., Tanaka T., Itano N., Kimata K., Fujii K. Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res. Ther. 2004, 6:R514-R520.
36. Ormiston M.L., Slaughter G.R., Deng Y., Stewart D.J., Courtman D.W. The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L148-L157.
37. Asari A., Kanemitsu T., Kurihara H. Oral administration of high molecular weight hyaluronan (900kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J. Biol. Chem. 2010, 285:24751-24758.
38. Liu Y.Y., Lee C.H., Dedaj R., Zhao H., Mrabat H., Sheidlin A., Syrkina O., Huang P.M., Garg H.G., Hales C.A., Quinn D.A. High-molecular-weight hyaluronan-a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit. Care 2008, 12:R102.
39. Mrabat H., Beagle J., Hang Z., Garg H.G., Hales C.A., Quinn D.A. Inhibition of HA synthase 3 mRNA expression, with a phosphodiesterase 3 inhibitor, blocks lung injury in a septic ventilated rat model. Lung 2009, 187:233-239.
40. Mummert M.E., Mohamadzadeh M., Mummert D.I., Mizumoto N., Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med. 2000, 192:769-779.
41. Guan H., Nagarkatti P.S., Nagarkatti M. Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. J. Immunol. 2007, 179:3715-3723.
42. Darenberg J., Soderquist B., Normark B.H., Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin. Infect. Dis. 2004, 38:836-842.